ICI-118,551
ICI-118,551 is a selective β2 adrenergic receptor antagonist. It is used in medical research to understand the function and action of the β2 receptor, due to its specificity and selectivity for this subtype. ICI-118,551 has been found to increase the contractility of the heart in studies on animals, suggesting potential therapeutic uses in heart failure. However, it is not currently used clinically for this purpose.
Pharmacology[edit]
ICI-118,551 is a selective antagonist for the β2 adrenergic receptor. This means it binds to these receptors and blocks their activation by agonists. It does not have significant activity at other adrenergic receptors, such as the β1 or β3 receptors.
Uses in Research[edit]
Due to its selectivity for the β2 receptor, ICI-118,551 is often used in research to understand the function of this receptor subtype. It has been used in studies investigating the role of the β2 receptor in the heart, lungs, and other tissues.
Potential Therapeutic Uses[edit]
In animal studies, ICI-118,551 has been found to increase the contractility of the heart. This suggests it could potentially be used to treat heart failure. However, further research is needed to confirm this potential use and to understand the safety and efficacy of ICI-118,551 in humans.
See Also[edit]
References[edit]
This WikiMD article can only be edited by registered and verified editors. You can log in or register.
-
ICI-118,551 chemical structure
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
